Tirzepatide’s Glowing Obesity Data Steal Show On Lilly’s Earnings Call

 
• By Joseph Haas
  
Head to head battle
Tirzepatide data in obesity may set up head-to-head battle between Lilly, Novo Nordisk • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business